My grandmother has stroke from last 3 yeras
"stroke" AND "long-term rehabilitation"
| Problem | What to Look For |
|---|---|
| Hemiplegia/weakness | Weakness or paralysis on one side of the body |
| Speech difficulties | Trouble speaking, finding words, or understanding (aphasia) |
| Swallowing difficulty | Choking on food or liquids (dysphagia) - a major risk for pneumonia |
| Depression | Very common after stroke - low mood, withdrawal, crying |
| Memory/thinking problems | Confusion, forgetting recent events (post-stroke dementia) |
| Spasticity | Stiff, tight muscles - painful if not managed |
| Urinary incontinence | Loss of bladder control |
| Pain | Central post-stroke pain or shoulder pain on the affected side |
| Falls | High risk due to weakness and balance problems |
| Pressure sores | If she spends a lot of time in bed or a wheelchair |
"Constrained movement therapy has been shown to improve hemiparesis following stroke, even years after the stroke, suggesting that physical therapy can recruit unused neural pathways. The human nervous system is more adaptable than previously thought."
| Risk Factor | Target |
|---|---|
| High blood pressure | < 130/80 mmHg |
| Atrial fibrillation | Anticoagulation if present |
| Diabetes | Well-controlled blood sugar |
| High cholesterol | LDL as low as possible with statin |
| Smoking | Must stop completely |
| Obesity | Healthy diet and activity |
She has tracheostomy from last 3 years ng tube and Foley catheter but now she is facing persistent uti and no antibiotics are sensitive
"catheter-associated urinary tract infection" AND "multidrug resistant"
"CAUTI" AND ("fosfomycin" OR "colistin" OR "polymyxin" OR "phage therapy")
"pandrug resistant" OR "pan-resistant" AND "urinary tract infection" AND treatment
"catheter associated UTI" AND ("catheter replacement" OR "intermittent catheterization" OR "suprapubic")
"A bacterial biofilm represents a microbial environment of microorganisms embedded in an extracellular matrix of bacterial products and host components. The bacterial biofilm prevents antibiotic contact with the bacteria and can result in CAUTI and antibiotic resistance."
"Patients with indwelling catheters should be treated only if they become symptomatic. Urine cultures should be performed initiating antimicrobial therapy. The antimicrobial agent should be discontinued within 48 hours..."
| Option | Notes |
|---|---|
| Change Foley catheter before starting each antibiotic course | Mandatory - urine culture should be from the new catheter |
| Intermittent catheterization instead of indwelling Foley | Greatly reduces infection rates if someone can perform this |
| Suprapubic catheter | Delays bacteriuria onset compared to urethral catheter; consider asking a urologist |
| Drug | What it covers | Notes |
|---|---|---|
| Ceftazidime-avibactam (Avycaz) | ESBL, KPC-type CRE, resistant Pseudomonas | IV, 2.5g every 8 hours |
| Cefiderocol (Fetroja) | Broadest coverage - ALL CRE types, Pseudomonas, Acinetobacter, Stenotrophomonas | IV, FDA-approved for complicated UTI; works even against metallo-beta-lactamase producers |
| Meropenem-vaborbactam | KPC-type CRE | IV |
| Imipenem-relebactam | KPC-type CRE, resistant Pseudomonas | IV |
| Aztreonam + ceftazidime-avibactam (combination) | MBL-producing organisms | Used when single agent fails |
| Colistin/Polymyxin B | Last resort for CRAB and pan-resistant gram-negatives | Significant kidney toxicity |
| Fosfomycin | Some multi-resistant E. coli and Klebsiella | Oral option in some countries for uncomplicated cases |
Most patients with long-term Foley catheters have bacteria in the urine without symptoms - this is called asymptomatic bacteriuria (ASB) and should NOT be treated with antibiotics.
| Priority | Action |
|---|---|
| Urgent | Get ID specialist consultation |
| Before next antibiotic | Change Foley catheter and get new urine culture |
| Ask about | Cefiderocol or ceftazidime-avibactam if pan-resistant CRE confirmed |
| Discuss with urologist | Possibility of switching to intermittent or suprapubic catheterization |
| Do NOT do | Repeat broad-spectrum antibiotics without new culture from fresh catheter |
Her foley has been removed from last 10 days but still its present
"urinary tract infection" AND "catheter removal" AND "persistent" AND "pyelonephritis"
"neurogenic bladder" AND "stroke" AND "urinary tract infection"
| Test | Why It Is Needed |
|---|---|
| Urine culture (midstream or clean catch) | Identify the organism and which drugs work - from a catheter-free sample now |
| Blood cultures x2 | Rule out urosepsis/bacteremia |
| Full blood count (FBC/CBC) | WBC count - is there systemic infection? |
| Kidney function tests (creatinine, urea) | Is the infection damaging her kidneys? |
| Ultrasound of kidneys and bladder | Look for: kidney swelling, abscess, hydronephrosis, how much urine remains in the bladder after voiding (post-void residual) |
| CT scan of abdomen/pelvis (with contrast) | Better than ultrasound for detecting renal abscess, emphysematous pyelonephritis (gas in kidney - a surgical emergency) |
| Post-void residual (PVR) bladder scan | Is there urine left in the bladder? If >300 mL, she needs catheterization again |
| Option | What It Means |
|---|---|
| Clean intermittent catheterization (CIC) | A catheter inserted 4-6 times daily and removed each time. Far lower infection rate than permanent Foley. Requires a trained caregiver. |
| Suprapubic catheter | Inserted through the abdomen into the bladder by a urologist. Avoids the urethra, slightly less infection than urethral Foley. |
| Botulinum toxin injection into the bladder | For overactive bladder causing retention. Reduces UTIs significantly. Done via cystoscopy. |
| Bladder training program | Stimulation techniques to encourage voluntary voiding - a specialist physiotherapist and urologist can assess |
No harmful sign till now
"asymptomatic bacteriuria" AND "catheter" AND "treatment"
"The IDSA guidelines do not recommend antimicrobial treatment in asymptomatic bacteriuria patients with indwelling catheters."
"Improper treatment of asymptomatic bacteriuria is often followed by improper testing for 'clearance' of bacteriuria, which results in a vicious cycle of escalating antimicrobial use and resistance."
| Symptom | What to Look For in Her Case |
|---|---|
| Fever (>38°C / 100.4°F) | Take her temperature regularly |
| New increased spasticity | Muscles becoming stiffer than usual (in stroke + neurological patients this can be a UTI sign) |
| Leakage around catheter site | If catheter was still in place |
| Suprapubic discomfort | Lower abdominal tightness - hard to assess if she cannot communicate |
| Worsening confusion | Sudden change in her level of awareness |
| Rapid breathing, fast pulse, low blood pressure | Signs of sepsis - requires immediate hospital care |
"In the event of a urine culture returning with Proteus spp., regardless of whether there are symptoms noted, recommended treatment is antimicrobial therapy for 10-21 days - as there is a chance of upper tract deterioration in the future due to kidney stone development."
| Action | Reason |
|---|---|
| Stop repeating antibiotics if she has no symptoms | This is causing resistance, not helping |
| Check the culture report for Proteus species | The one exception requiring treatment |
| Monitor for symptoms daily (fever, spasticity, confusion) | Treat only if symptoms develop |
| Keep good fluid intake via NG tube | Adequate hydration flushes bacteria naturally |
| Good perineal hygiene | Clean the urethral area with plain water daily |
| Bladder scan to check post-void residual | Is she retaining urine? If yes, intermittent catheterization may be needed |
She also has active chest infection but amikacin is sensitive to pseudomonas
"Pseudomonas aeruginosa" AND "pneumonia" AND "amikacin"
"Amikacin has concentration-dependent activity against most gram-negative organisms including P. aeruginosa. The postantibiotic effect and concentration-dependent killing form the rationale behind extended-interval aminoglycoside dosing - a larger dose given once daily rather than smaller doses multiple times daily."
"Add an aminoglycoside empirically for patients in shock and in regions where rates of resistance to primary beta-lactam agents are high. Combination therapy with a beta-lactam agent is standard for Pseudomonas pneumonia."
| Drug Class | Example | Why |
|---|---|---|
| Anti-pseudomonal beta-lactam | Piperacillin-tazobactam (Tazocin) 4.5g IV every 6h | Primary drug that attacks cell wall |
| OR | Cefepime 2g IV every 8h | Alternative beta-lactam |
| OR | Meropenem 1-2g IV every 8h | If resistant to above |
| OR | Ceftazidime 2g IV every 8h | |
| + Amikacin (the sensitive drug) | 15-20 mg/kg IV once daily | Synergistic killing, postantibiotic effect |
| Monitor | Frequency | Target |
|---|---|---|
| Serum creatinine and urea (kidney function) | Every 2-3 days | Creatinine should not rise |
| Amikacin drug levels (therapeutic drug monitoring) | Peak level 1h after dose: 20-30 mg/L; Trough level just before next dose: <5 mg/L | Prevents toxicity |
| Urine output | Daily | Should be at least 0.5 mL/kg/hr |
| Hearing assessment | If course >7 days | Watch for new hearing loss |
| Dose adjustment | If creatinine rises | Dose must be reduced or interval extended |
| Intervention | Why It Matters |
|---|---|
| Regular suctioning of tracheostomy | Pseudomonas thrives in pooled secretions - they must be removed |
| Chest physiotherapy | Vibration and positioning to drain secretions from all lung segments |
| Humidification of tracheostomy air | Prevents secretion crusting and blockage |
| Head of bed elevated 30-45 degrees | Reduces aspiration of oral/gastric contents into lungs |
| Tracheostomy tube cuff pressure check | Should be 20-25 cmH2O - prevents aspiration around the tube |
| Regular tracheostomy tube changes | Biofilm forms on the tube just like on the Foley - regular changes are essential |
| Adequate nutrition via NG tube | Malnourished patients cannot fight infection |
| Oral hygiene | Brush teeth and clean mouth twice daily - reduces bacteria that aspirate into lungs |
| Issue | Status | Action |
|---|---|---|
| Pseudomonas chest infection | Active - must treat | Amikacin + beta-lactam combination; monitor kidneys and drug levels |
| UTI - no symptoms | Lower priority | Do NOT use amikacin for the UTI - amikacin IV penetrates urine but this is not the right approach if no symptoms |
| Amikacin side effects | High risk in this patient | Kidney function and drug level monitoring every 2-3 days |
| Non-antibiotic lung care | Essential | Suctioning, physiotherapy, head elevation, tube hygiene |
Should i give her piperacillim tazobactam also ?
"piperacillin tazobactam" AND "Pseudomonas" AND "amikacin" AND combination
"Piperacillin-tazobactam OR cefepime OR antipseudomonal carbapenem + aminoglycoside (amikacin/tobramycin)"
"Early empiric antibiotic therapy generally requires an intravenous beta-lactam with broad gram-negative rod activity, such as piperacillin-tazobactam, cefepime, or ceftazidime."
| Sensitivity Report Result | What It Means | What to Do |
|---|---|---|
| Sensitive (S) to pip-taz | The drug will work against this strain | ✅ Yes, use pip-taz + amikacin combination |
| Intermediate (I) to pip-taz | May work at higher doses / extended infusion | Discuss with doctor - may still be usable |
| Resistant (R) to pip-taz | Will not work even if given | ❌ Do not use pip-taz - choose alternative beta-lactam |
| Drug | Notes |
|---|---|
| Cefepime (2g IV every 8h) | Often active even when pip-taz is resistant |
| Ceftazidime (2g IV every 8h) | Good anti-pseudomonal activity |
| Meropenem (1-2g IV every 8h) | Carbapenem - broadest coverage, use if others resistant |
| Imipenem (500mg IV every 6h) | Alternative carbapenem |
Is Pseudomonas sensitive to pip-taz on the culture?
|
YES → Give Pip-Taz 4.5g IV every 6h + Amikacin 15-20mg/kg once daily ✅
|
NO → Check: sensitive to cefepime?
YES → Cefepime 2g IV every 8h + Amikacin ✅
NO → Meropenem 1-2g IV every 8h + Amikacin ✅
| Monitor | Why |
|---|---|
| Kidney function (creatinine) every 2-3 days | Both pip-taz and amikacin can affect kidneys |
| Amikacin drug levels (peak and trough) | Prevent amikacin toxicity |
| Signs of diarrhea / loose stool | Pip-taz can cause C. difficile colitis |
| Liver enzymes after 1 week | Pip-taz can occasionally cause elevated liver enzymes |
| Total duration | Aim for 7 days if good clinical response - not longer |
I m her caretaker and pip taz is labelled as intermediate
"piperacillin-tazobactam" AND "intermediate" AND "Pseudomonas" AND "extended infusion"
"piperacillin-tazobactam" AND "extended infusion" AND "Pseudomonas" AND pneumonia
"piperacillin-tazobactam" AND "intermediate susceptibility" AND gram-negative
piperacillin tazobactam intermediate susceptibility Pseudomonas pneumonia extended infusion EUCAST 2024
"The intermediate breakpoint of 32/4 µg/mL for piperacillin-tazobactam against P. aeruginosa is meant only to account for technical variability inherent to susceptibility testing and does not imply dose-dependent susceptibility. Administration of piperacillin-tazobactam against P. aeruginosa isolates with MIC 32/4 mcg/mL is not advised."
| Result | Meaning for Pseudomonas Chest Infection |
|---|---|
| Sensitive (S) to pip-taz | Safe to use - standard or extended infusion |
| Intermediate (I) to pip-taz | Do NOT use - clinical failure expected |
| Resistant (R) to pip-taz | Do not use |
| Drug | If Sensitive - Can Use With Amikacin |
|---|---|
| Cefepime (2g IV every 8h) | First choice alternative - good anti-pseudomonal activity |
| Ceftazidime (2g IV every 8h) | Good option |
| Meropenem (1-2g IV every 8h) | If resistant to above - carbapenem |
| Imipenem (500mg IV every 6-8h) | Alternative carbapenem |
| Ceftazidime-avibactam | If resistant to all standard carbapenems |
"The sputum culture shows pip-taz as intermediate for Pseudomonas. I have read that the FDA 2024 guidance says intermediate pip-taz for Pseudomonas should not be used clinically. Can we check what the sensitivity is for cefepime, ceftazidime, or meropenem on the same culture report, and use one of those with amikacin instead?"
All of them are resistant
pan resistant Pseudomonas aeruginosa pneumonia treatment options 2024 2025 cefiderocol colistin
"pandrug resistant Pseudomonas" AND treatment
https://www.idsociety.org/practice-guideline/amr-guidance
"The panel suggests always obtaining AST (antibiotic sensitivity testing) results for the four newer beta-lactam agents for DTR P. aeruginosa infections to guide treatment decisions."
| Drug | Why It May Work | IDSA 2024 Status |
|---|---|---|
| Ceftolozane-tazobactam (Zerbaxa) | Novel cephalosporin that overcomes most Pseudomonas resistance mechanisms | First-line preferred for DTR Pseudomonas pneumonia |
| Ceftazidime-avibactam (Avycaz) | Avibactam blocks beta-lactamase enzymes that destroy cephalosporins | First-line preferred |
| Imipenem-cilastatin-relebactam (Recarbrio) | Relebactam restores imipenem activity against resistant strains | First-line preferred |
| Cefiderocol (Fetroja) | Siderophore cephalosporin - enters bacteria via iron channels, bypassing ALL known resistance mechanisms | Active against ~99% of carbapenem-resistant Pseudomonas - ESCMID 2025 data |
"Please test sensitivity to ceftolozane-tazobactam, ceftazidime-avibactam, imipenem-relebactam, and cefiderocol"
"My grandmother has a tracheostomy with sputum culture showing pan-resistant Pseudomonas aeruginosa - resistant to pip-taz (intermediate), cefepime, ceftazidime, meropenem, imipenem. Amikacin is the only sensitive drug. We need extended susceptibility testing for newer agents and specialist guidance."
| Option | Availability | Action Needed |
|---|---|---|
| Amikacin alone | Already confirmed sensitive | Use NOW at 20mg/kg once daily with monitoring |
| Ceftolozane-tazobactam | Specialist hospital | Test sensitivity urgently |
| Ceftazidime-avibactam | Specialist hospital | Test sensitivity urgently |
| Imipenem-relebactam | Specialist hospital | Test sensitivity urgently |
| Cefiderocol | Specialist hospital | Most likely to work - test urgently |
| Colistin + amikacin | Most hospitals | Last resort if newer drugs not available or not sensitive |
| Bacteriophage therapy | Research centers only | Experimental - only if everything else fails |
We will treat her at home only please help me out
| Parameter | Requirement |
|---|---|
| Dose | 15-20 mg/kg IV ONCE daily (not twice or three times - once daily is safer for kidneys) |
| Route | IV only - through a vein cannula or PICC line |
| Duration | 7-14 days for chest infection |
| Kidney function check | Serum creatinine and urea BEFORE starting, then every 3 days |
| Drug levels | Peak level 1 hour after infusion: aim 20-30 mg/L; Trough just before next dose: must be less than 5 mg/L |
| Urine output | Watch daily - if she passes less urine or swelling in legs develops, stop and seek help |
| Hearing | If she responds less to sound or family voices, inform doctor immediately |
| Warning Sign | What It Means |
|---|---|
| Temperature above 39°C (102°F) OR below 36°C (96.8°F) | Worsening sepsis |
| Breathing rate above 30 breaths per minute | Respiratory failure |
| Lips or fingertips turning blue | Oxygen levels critically low |
| Tracheostomy tube blocked - cannot pass suction catheter | Airway emergency - call ambulance immediately |
| No urine output for 8+ hours | Kidney failure from amikacin or sepsis |
| She becomes completely unresponsive / cannot be roused | Critical deterioration |
| Green/brown thick secretions increasing despite treatment | Infection worsening |
| Time | Action |
|---|---|
| Every 2 hours | Turn her position, suction tracheostomy |
| 3x daily | Chest physiotherapy (tapping), NG tube feeds |
| 2x daily | Clean inner tracheostomy cannula, mouth care |
| Once daily | Amikacin IV (prescribed by doctor), check temperature, check urine output |
| Every 3 days | Blood test for kidney function (creatinine) |